An Expert View from Robert Wessman, chairman and CEO at global pharmaceutical company Alvogen, and founder and chairman at biopharma specialist, Alvotech. 25 May 2022
It’s just got tougher for biotech companies – especially those at an early-stage where risk is greater – to access the talent essential to develop a successful 9 May 2022
An Expert View from Neelam Patel, chief executive of MedCity, a not-for-profit that serves as the life sciences cluster organization for London. 2 May 2022
The pharmaceutical industry is faced by a multi-dimensional challenge of revenues under pressure, increasing regulatory requirements which differ across local 23 March 2022
An Expert View from Jennifer Romanski, a principal of Porzio, Bromberg & Newman and a co-chair of its Life Sciences Compliance and Regulatory Counseling Departm 18 March 2022
Kathleen Rickard, chief medical officer, Verona Pharma, with an Expert View to educate other executives who are considering going down the remote/flexible route 4 March 2022
Kate Corke, partner and Christina Tennant, senior counsel at Farrer & Co, provide an Expert View on real estate for the UK’s life sciences sector. 18 February 2022
An Expert View providing best practices on developing a sound commercial strategy.building out secure logistics platforms.and creating a connected ecosystem thr 14 February 2022
Adrian Tombling, partner and life sciences sector specialist at European intellectual property firm, Withers & Rogers, offers an Expert View on why patents are 4 January 2022
Real world evidence (RWE) continues to grow as a promising frontier in evidence generation to support positive health outcomes.It can be useful in evaluating un 13 December 2021
An Expert View on the importance of embedding a modern quality culture from David Fryrear, executive vice president and head of quality assurance, Medical and D 9 December 2021
Vicki Pearson, global solutions architect, life sciences at Schneider Electric, provides an Expert View on how firms can meet a growing demand while remaining a 30 November 2021
Ester Banque, senior vice president and head of intercontinental commercial at Bristol Myers Squibb, provides an Expert View on coping with 'The Great Resignati 12 November 2021
The National Institute for Health and Care Excellence's (NICE) consultation on the proposed changes to its methods and processes of health technology assessment 5 November 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.